Alternate Health Corp. (AHGIF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 4, 2025
Alternate Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
Operating Revenue | 4.43 | 0.58 | 13.25 | 0.18 | 0.17 | 0.01 |
Other Revenue | - | - | - | - | 0 | - |
| 4.43 | 0.58 | 13.25 | 0.18 | 0.17 | 0.01 | |
Revenue Growth (YoY) | 267.51% | -95.65% | 7121.51% | 9.54% | 1994.44% | - |
Cost of Revenue | 1.91 | 1.91 | 3.05 | - | 0.01 | 0.11 |
Gross Profit | 2.51 | -1.34 | 10.21 | 0.18 | 0.16 | -0.1 |
Selling, General & Admin | 10.75 | 13.72 | 26.34 | 1.39 | 0.29 | 0.42 |
Research & Development | 0.48 | 0.48 | 0.51 | - | - | 0.01 |
Operating Expenses | 10.93 | 18.05 | 28.64 | 1.83 | 0.37 | 0.43 |
Operating Income | -8.42 | -19.38 | -18.43 | -1.65 | -0.21 | -0.54 |
Interest Expense | -1.54 | -0.54 | -0.09 | -0.07 | -0.02 | -0 |
Interest & Investment Income | - | - | 0.08 | - | - | 0 |
Earnings From Equity Investments | - | - | 0.3 | - | - | - |
Currency Exchange Gain (Loss) | -0.17 | -0.16 | -0.03 | -0.02 | - | - |
Other Non Operating Income (Expenses) | -0 | - | - | - | -0 | -0 |
EBT Excluding Unusual Items | -10.12 | -20.09 | -18.18 | -1.73 | -0.23 | -0.54 |
Merger & Restructuring Charges | - | - | -0.03 | -0.11 | - | - |
Impairment of Goodwill | - | - | 2.25 | - | - | - |
Gain (Loss) on Sale of Investments | -1.85 | 1.34 | -9.17 | - | - | - |
Gain (Loss) on Sale of Assets | -0.46 | -0.46 | - | - | - | - |
Asset Writedown | -4.64 | -4.1 | -3.05 | - | - | - |
Other Unusual Items | -0.68 | -0.68 | -0.46 | -0.64 | - | - |
Pretax Income | -17.74 | -23.99 | -28.64 | -2.48 | -0.23 | -0.54 |
Income Tax Expense | -0 | - | -2.51 | -0.43 | - | - |
Net Income | -17.74 | -23.99 | -26.13 | -2.05 | -0.23 | -0.54 |
Net Income to Common | -17.74 | -23.99 | -26.13 | -2.05 | -0.23 | -0.54 |
Shares Outstanding (Basic) | 73 | 54 | 50 | 31 | 29 | 27 |
Shares Outstanding (Diluted) | 73 | 54 | 50 | 31 | 29 | 27 |
Shares Change (YoY) | 38.32% | 8.86% | 60.14% | 5.41% | 9.53% | - |
EPS (Basic) | -0.24 | -0.44 | -0.53 | -0.07 | -0.01 | -0.02 |
EPS (Diluted) | -0.24 | -0.44 | -0.53 | -0.07 | -0.01 | -0.02 |
Free Cash Flow | -5.67 | -11.69 | -7.31 | -0.72 | -0.29 | 0.23 |
Free Cash Flow Per Share | -0.08 | -0.22 | -0.15 | -0.02 | -0.01 | 0.01 |
Gross Margin | 56.82% | -231.36% | 76.99% | 100.00% | 96.67% | - |
Operating Margin | -190.12% | -3358.19% | -139.05% | -897.36% | -123.70% | -6721.05% |
Profit Margin | -400.88% | -4156.17% | -197.17% | -1118.64% | -139.23% | -6727.91% |
Free Cash Flow Margin | -128.10% | -2024.57% | -55.16% | -392.31% | -171.39% | 2908.14% |
EBITDA | -7.82 | -18.41 | -17.2 | -1.64 | -0.2 | -0.54 |
EBITDA Margin | -176.63% | - | -129.78% | - | -122.25% | - |
D&A For EBITDA | 0.6 | 0.97 | 1.23 | 0 | 0 | 0 |
EBIT | -8.42 | -19.38 | -18.43 | -1.65 | -0.21 | -0.54 |
EBIT Margin | -190.12% | - | -139.05% | - | -123.70% | - |
Revenue as Reported | - | - | - | - | 0.17 | 0.01 |
Advertising Expenses | - | 0.26 | 0.28 | 0.12 | - | 0.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.